Ro Khanna bought CVS Health Corp (NYSE: CVS)
Ro Khanna bought CVS · disclosed July 6, 2026
Ro Khanna, a CA House member representing District 17, purchased $1,001 - $15,000 of CVS Health Corp (CVS) on June 2, 2026. Filings associated with Ro Khanna disclosed 5 other CVS transactions (4 purchases and 1 sale) in the 12 months before this trade. Shares of CVS have risen 64.8% since the first observed purchase on April 3, 2017. The filing was publicly disclosed on July 6, 2026; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Ro Khanna's complete filing history, visit Ro Khanna's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on CVS break down as 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell.
- CVS carries a Risk Score of 94 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Ro Khanna bought CVS in the amount range of $1,001 - $15,000 on June 2, 2026, filed under the STOCK Act.
- The filing lists Dependent child as the transaction owner and was disclosed 34 days after the trade.
- The asset description in the filing reads 'CVS HEALTH CORP (CMN).'
- Filings associated with Ro Khanna disclosed 5 other CVS transactions (4 purchases and 1 sale) in the 12 months before this trade.
- Shares of CVS have risen 64.8% since the first observed purchase on April 3, 2017.
- CVS carried a Q Score of 63.7 in its equity peer group as of September 8, 2026.
- CVS carried a Squeeze Score of 14 as of September 9, 2026.
Did Ro Khanna buy or sell CVS?
The Periodic Transaction Report covers a single purchase involving CVS on June 2, 2026. The filed amount range is $1,001 - $15,000. The asset description reads 'CVS HEALTH CORP (CMN)', as submitted by the filer. The report was submitted on July 6, 2026. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Ro Khanna (House) | Buy | CVS | $1,001 - $15,000 | June 2, 2026 | July 6, 2026 |
What other CVS trades has Ro Khanna disclosed in the past 12 months?
Filings associated with Ro Khanna disclosed 5 other CVS transactions (4 purchases and 1 sale) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| May 15, 2026 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
| May 1, 2026 | Buy | Dependent child | $1,001 - $15,000 | Filing unavailable |
| April 13, 2026 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
| February 24, 2026 | Sell | Dependent child | $1,001 - $15,000 | Filing unavailable |
| January 29, 2026 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a purchase involving CVS by Ro Khanna in the amount range of $1,001 - $15,000, with Dependent child listed as the owner. It does not establish Ro Khanna's total holdings in CVS, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'CVS HEALTH CORP (CMN)', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Ro Khanna's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Ro Khanna disclosed 5 other CVS transactions (4 purchases and 1 sale) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded CVS?
Quantellect's current database lists these recent CVS disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Alan Armstrong Self | R Senate | Buy | $1,001 - $15,000 | July 21, 2026Filing unavailable |
| Michael T. McCaul Spouse | R House | Buy | $15,001 - $50,000 | March 10, 2026Filing unavailable |
| John Boozman Joint | R Senate | Buy | $1,001 - $15,000 | February 15, 2026Filing unavailable |
| Michael T. McCaul Spouse | R House | Sell | $15,001 - $50,000 | February 11, 2026Filing unavailable |
| Dwight Evans Self | D House | Sell | $1,001 - $15,000 | December 19, 2025Filing unavailable |
How has Ro Khanna's disclosed trading performed?
Ro Khanna holds a Quantellect Q Score of 90 (elite), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #9 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Ro Khanna CVS trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Ro Khanna buy or sell CVS?
According to the disclosure, Ro Khanna purchased CVS on June 2, 2026.
What amount was reported for the CVS transaction?
The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated June 2, 2026, and it was disclosed on July 6, 2026.
Where can I see Ro Khanna's other congressional trades?
Quantellect lists Ro Khanna's complete disclosed trade history on the member profile. Ro Khanna's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.